Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: Treatment with meclizi...
Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: Treatment with meclizine
About this item
Full title
Author / Creator
Publisher
England: American Society of Health-System Pharmacists
Journal title
Language
English
Formats
Publication information
Publisher
England: American Society of Health-System Pharmacists
Subjects
More information
Scope and Contents
Contents
The case of a patient who treated withdrawal symptoms from trans-dermal scopolamine with meclizine is reported.
A 30-year-old woman for whom transdermal scopolamine was prescribed to manage motion sickness during a vacation experienced severe withdrawal symptoms that began 24 hours after patch removal and lasted for several days. Other medicatio...
Alternative Titles
Full title
Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: Treatment with meclizine
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_733614723
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_733614723
Other Identifiers
ISSN
1079-2082
E-ISSN
1535-2900
DOI
10.2146/ajhp080569
